Smith & Nephew Pays $22.2M Settlement in SEC Investigation

Smith & Nephew has reached a settlement with the U.S. Securities and Exchange Commission and the U.S. Department of Justice in connection with their Foreign Corrupt Practices Act investigation, according to a company news release.

Advertisement

Smith & Nephew agreed to pay more than $22.2 million in fines and profit disgorgement, maintain an enhanced compliance program and appoint an independent monitor for at least 18 months to review the program.

The company was one of multiple medical device companies asked to investigate improper payments to government-employed physicians and voluntarily report issues in 2007. The company found and reported payments by a Greek distributor, which was terminated in 2008.

The company provided for the payment in its fourth quarter 2011 earnings.


Sign up for our FREE Orthopedic E-Weekly for more coverage like this sent to your inbox!

Related Articles on Orthopedic Device Companies:
TeDan Surgical Innovations Launches Minimally Invasive Anterior Hip Retractor System
ConforMIS Received 22 Patents Over Last Year

Exactech Reports 21% Decline in 4Q Spine & Biologics Sales

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • SurGenTec’s ION-C earned FDA 510(k) clearance for ION-C navigation instruments with the ION-C posterior cervical facet fixation implant, according to…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.